Apriso 375 MG 24 HR Extended Release Oral Capsule

RxCUI: 825134
RxNorm name: Apriso 375 MG 24 HR Extended Release Oral Capsule
Display name: Apriso 375 MG 24 HR Extended Release Oral Capsule
Full name: Apriso 375 MG 24 HR Extended Release Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
APRISO	MESALAMINE	Salix Pharmaceuticals, Inc.	7951139c-b271-45a4-b523-34b23800917b	2024-01-09	Warnings, Adverse reactions	Exact identifier rxcui: 825134

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7951139c-b271-45a4-b523-34b23800917b	Apriso 375 MG 24 HR Extended Release Oral Capsule	SY	34	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20240109
7951139c-b271-45a4-b523-34b23800917b	Apriso 0.375 GM 24HR Extended Release Oral Capsule	PSN	34	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20240109
7951139c-b271-45a4-b523-34b23800917b	24 HR mesalamine 375 MG Extended Release Oral Capsule [Apriso]	SBD	34	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20240109
d5d05b1f-9f45-4f66-9f75-3c67934105de	24 HR mesalamine 375 MG Extended Release Oral Capsule [Apriso]	SBD	2	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20120215
d5d05b1f-9f45-4f66-9f75-3c67934105de	Apriso 375 MG 24 HR Extended Release Oral Capsule	SY	2	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20120215
d5d05b1f-9f45-4f66-9f75-3c67934105de	Apriso 0.375 GM 24HR Extended Release Oral Capsule	PSN	2	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20120215